sever
acut
respiratori
syndrom
sar
new
diseas
origin
guangdong
provinc
china
novemb
subsequ
spread
hong
kong
februari
facilit
busi
intern
traffic
soon
caus
major
diseas
outbreak
multipl
citi
around
world
follow
five
month
alarm
tendenc
spread
health
care
worker
unlik
respiratori
viral
infect
predominantli
involv
lower
respiratori
tract
diseas
associ
unusu
high
morbid
mortal
patient
develop
sever
respiratori
symptom
requir
intens
care
support
worldwid
averag
case
mortal
rate
hong
kong
toronto
case
mortal
rate
older
patient
chronic
ill
wors
outcom
caus
agent
determin
novel
coronaviru
sarscov
genet
distinct
previous
identifi
coronaviru
known
caus
diseas
anim
human
primat
model
system
experiment
infect
cynomolgu
macaqu
sarscov
alon
suffici
caus
diseas
complex
similar
observ
human
genet
coronaviru
speci
closest
sarscov
isol
small
anim
trade
culinari
purpos
himalayan
palm
civet
raccoondog
show
sequenc
homolog
differ
insert
fragment
postul
coronavirus
probabl
arisen
common
natur
reservoir
facilit
interspeci
transmiss
possibl
genet
alter
sarscov
close
handl
trade
anim
environ
pulmonari
patholog
observ
limit
postmortem
materi
report
togeth
clinic
symptomatolog
sar
detect
coronaviru
relat
pulmonari
chang
critic
factor
understand
pathogenesi
diseas
howev
hamper
lack
readili
avail
monoclon
antisar
antibodi
well
impractic
extens
electron
microscop
examin
furthermor
although
investig
time
cours
sarscov
infect
respect
detect
sarscov
rna
done
pcr
method
systemat
largescal
investig
tempor
cellular
detect
sarscov
lung
tissu
addit
extent
organ
distribut
examin
great
detail
inde
recent
singlecas
public
immunohistochem
detect
sar
highlight
need
case
sar
studi
determin
tempor
relationship
durat
ill
viral
clearanc
human
lung
studi
therefor
three
purpos
first
investig
presenc
sarscov
immunohistochemistri
ihc
situ
hybrid
ish
lung
autopsi
specimen
patient
die
differ
time
point
diseas
second
purpos
determin
cellular
distribut
sar
within
lung
third
examin
extrapulmonari
tissu
patient
die
sar
determin
extent
system
distribut
total
patient
die
sarscov
infect
confirm
pcr
serolog
viral
cultur
test
includ
studi
patient
came
two
geograph
region
affect
sar
hong
kong
hk
toronto
canada
hk
case
whole
lung
specimen
perfus
autopsi
neutral
buffer
formalin
cm
pressur
lung
fulli
expand
immers
formalin
fix
multipl
block
extens
sampl
lobe
lung
hk
case
limit
repres
block
sampl
hk
case
toronto
case
approxim
half
lung
lobe
remov
autopsi
portion
snapfrozen
molecular
studi
multipl
block
tissu
process
lobe
light
microscop
examin
stain
microorgan
collagen
immunohistochem
stain
microorgan
perform
necessari
clinic
profil
retriev
patient
record
hk
case
patient
die
quarantin
period
sar
exposur
hospit
congest
heart
failur
pcr
throat
swab
posit
fifth
day
symptom
onset
develop
fever
respiratori
symptom
thereaft
hk
case
patient
die
unexpectedli
convalesc
sar
patient
die
sar
progress
deterior
lung
function
hk
patient
except
case
receiv
ventilatori
support
life
pulmonari
histopatholog
featur
six
hk
case
previous
report
addit
autopsi
tissu
hk
case
hk
case
also
open
lung
biopsi
also
includ
studi
descript
procur
clinic
cours
case
describ
previou
report
balbc
mice
immun
intraperiton
ml
heatkil
sarscov
cell
lysat
inject
similar
dose
repeat
biweekli
mo
four
day
last
booster
spleen
cell
immun
mous
fuse
nsi
myeloma
cell
polyethylen
glycol
peg
molecular
weight
bdh
pool
unit
kingdom
fuse
agent
hybridoma
screen
product
antibodi
sarscov
cell
recombin
sarscov
nucleocapsid
protein
elisa
produc
sarscov
nucleoproteinspecif
antibodi
clone
twice
limit
dilut
purifi
hybridoma
inject
intraperiton
miner
oilprim
mice
product
ascit
fluid
monoclon
antibodi
purifi
ascit
fluid
precipit
ammonium
sulfat
subclon
ensur
monoclon
open
read
frame
spike
envelop
e
n
gene
sarscov
clone
agei
site
protein
express
vector
express
viral
protein
eukaryot
cell
protein
express
plasmid
transfect
cell
individu
appropri
combin
briefli
plasmid
transfect
cell
lipofectamin
invitrogen
carlsbad
california
unit
state
instruct
manufactur
indic
posttransfect
time
point
transfect
cell
harvest
wash
pb
centrifug
rpm
min
pellet
cell
fix
pb
glutaraldehyd
formaldehyd
store
sarscov
e
genetransfect
cell
use
neg
control
sarscov
n
genetransfect
cell
use
posit
control
ihc
confirm
specif
monoclon
antibodi
sarscov
nucleoprotein
primari
antibodi
use
includ
cytokeratin
clone
dako
glostrup
denmark
clone
dako
ema
clone
dako
thyroid
transcript
factor
clone
zymedinvitrogen
chromogranin
clone
ventana
tucson
arizona
unit
state
dcsign
gift
professor
jl
virilizi
pasteur
institut
pari
franc
lca
clone
dako
sarscov
n
describ
clone
antigen
retriev
perform
microwav
section
mm
citrat
buffer
ph
min
incub
antibodi
overnight
secondari
label
perform
biotinyl
rabbit
antimous
dako
min
room
temperatur
follow
incub
streptavidinabc
complex
dako
min
room
temperatur
color
develop
aec
substrat
kit
vector
laboratori
burlingam
california
unit
state
room
temperatur
min
doubl
label
lung
tissu
section
antibodi
label
fitc
tritc
antimous
secondari
antibodi
use
section
microwav
mm
citrat
buffer
ph
min
block
normal
donkey
serum
min
room
temperatur
incub
nonsar
monoclon
overnight
incub
tritcconjug
donkey
antimous
antibodi
h
room
temperatur
fitcconjug
antibodi
incub
h
room
temperatur
follow
counterstain
nuclei
dapi
min
mount
dako
fluoresc
mount
dako
examin
perform
nikon
eclips
fluoresc
microscop
dual
fitcrhodamin
filter
produc
digoxigeninlabel
antisens
riboprob
specif
n
e
gene
sarscov
pool
hybrid
proteinas
ktreat
lung
section
min
room
temperatur
hybrid
buffer
salmon
sperm
dna
rat
total
rna
mgml
yeast
trna
deioniz
formamid
dextran
sulfat
denhardt
solut
mm
edta
ph
sodium
pyrophosph
sodium
chlorid
mm
trishcl
ph
mix
probe
hybrid
overnight
hybrid
probe
detect
mous
antidigoxigenin
normal
rabbit
serum
h
room
temperatur
biotinyl
rabbit
antimous
dako
min
room
temperatur
follow
detect
aec
substrat
kit
vector
room
temperatur
min
prior
test
sensit
sarscov
probe
verifi
semiquantit
hybrid
separ
cell
block
prepar
sarscov
infect
cell
line
harvest
h
sarscov
rtpcr
complet
fresh
hk
case
fix
hk
case
snapfrozen
case
lung
tissu
patient
hk
case
total
rna
extract
standard
method
revers
transcrib
cdna
revers
transcriptas
pcr
perform
initi
denatur
min
follow
cycl
min
min
min
use
primer
previous
describ
case
rtpcr
complet
use
realart
hpacoronaviru
lcrt
assay
artu
hamburg
germani
previous
describ
hk
patient
die
symptom
onset
quarantin
sar
contact
show
moder
interstiti
alveolar
edema
occasion
epitheli
desquam
regener
moder
number
macrophag
abund
foami
cytoplasm
accumul
alveolar
space
giant
cell
observ
addit
featur
aspir
pneumonia
present
involv
small
bronchi
adjac
parenchyma
lobe
lung
hk
patient
show
establish
chang
indic
diffus
alveolar
damag
dad
differ
phase
diseas
progress
affect
lung
vari
extent
lung
patholog
case
describ
previous
although
advanc
histolog
chang
reveal
dad
attribut
ventil
point
also
chang
dad
present
five
case
intub
carri
thu
viral
damag
therefor
like
mechan
chang
transfect
cell
show
strong
cytoplasm
stain
transfect
contain
n
gene
stain
gene
transfect
figur
confirm
specif
monoclon
antibodi
n
protein
control
section
cell
show
cytoplasm
stain
focal
h
diffus
h
four
case
show
posit
stain
n
protein
ihc
hk
case
case
figur
four
case
die
within
symptom
onset
stain
bronchial
epithelium
present
figur
focal
stain
bronchiolar
epithelium
figur
show
evid
necrosi
regener
observ
confirm
electron
microscopi
viral
particl
identifi
ciliat
cell
cytoplasm
stain
flatten
type
pneumocyt
well
alveolar
macrophag
figur
adjac
hilar
lymph
node
avail
examin
one
case
hk
case
six
node
sampl
patient
one
isol
mononuclear
cell
note
stain
posit
n
protein
neg
n
gene
ish
although
stain
pneumocyt
diffus
cytoplasm
stain
alveolar
macrophag
coars
granular
figur
patient
die
beyond
symptom
onset
scatter
singl
posit
cell
seen
lung
section
figur
flatten
pneumocyt
well
mononuclear
cell
one
toronto
case
case
thrombu
identifi
figur
posit
elong
cell
well
round
mononuclear
cell
identifi
thrombu
thrombu
present
one
section
label
confirm
etiolog
infect
cell
could
perform
none
multinucl
epitheli
cell
seen
patient
posit
ish
ihc
four
case
stain
posit
n
protein
ihc
doubl
label
directli
conjug
fitc
sar
monoclon
antibodi
antibodi
macrophag
epitheli
cell
show
infect
cell
posit
ema
antiepitheli
antimacrophag
figur
number
infect
cell
greatest
case
hk
case
die
symptom
onset
interest
case
show
posit
stain
epitheli
cell
stain
macrophag
figur
macrophag
show
posit
coars
granular
stain
hk
case
case
die
symptom
onset
respect
figur
stain
seen
chromograninposit
dcsignposit
cell
coloc
marker
type
pneumocyt
seen
stain
lymphocyt
identifi
case
die
day
symptom
onset
scatter
singl
posit
cell
flatten
epitheli
cell
mononuclear
cell
four
case
show
posit
stain
n
protein
ihc
hk
case
case
also
posit
ish
pool
e
n
sarscov
gene
multipl
lung
sampl
hk
case
show
strong
cytoplasm
signal
alveolar
cell
includ
desquam
pneumocyt
alveolar
macrophag
weak
signal
detect
occasion
macrophag
scatter
along
bronchial
epithelium
signal
detect
endotheli
stromal
cell
addit
four
case
stain
posit
sarscov
ihn
ish
sarscov
infect
cell
also
detect
ish
ihc
open
lung
biopsi
taken
symptom
onset
hk
case
howev
ish
ihc
neg
autopsi
lung
sampl
taken
patient
death
symptom
onset
result
rtpcr
list
tabl
autopsi
lung
sampl
three
hk
case
posit
sarscov
rtpcr
ihc
ish
stain
compar
rtpcr
viral
load
diseas
durat
posit
cell
ihc
ish
identifi
mainli
case
die
less
onset
ill
lung
tissu
associ
viral
load
greater
copi
per
gram
tissu
two
case
posit
ihc
lung
organ
examin
ihc
hk
case
strong
posit
ihc
ish
stain
lung
identifi
ihc
ishposit
cell
identifi
organ
examin
adren
gland
kidney
spleen
liver
heart
case
also
show
posit
lung
stain
organ
posit
ihc
ish
liver
spleen
kidney
examin
three
case
stain
neg
lung
also
show
posit
extrapulmonari
stain
sarscov
nucleocapsid
protein
rna
detect
lung
autopsi
sampl
four
seven
patient
die
within
wk
ill
onset
high
greater
copi
per
gram
rtpcr
viral
load
autopsi
lung
tissu
sarscov
nucleocapsid
protein
rna
also
detect
open
lung
biopsi
patient
day
symptom
onset
death
patient
autopsi
lung
specimen
collect
day
symptom
onset
among
lung
sampl
stain
posit
ish
ihc
signal
local
mainli
alveolar
epitheli
cell
lower
intens
alveolar
macrophag
indic
former
chief
target
cell
viru
scatter
posit
cell
identifi
bronchiolar
epithelium
signific
stain
bronchial
epithelium
observ
distinct
spread
region
lymph
node
seen
abl
determin
coloc
cell
use
oligonucleotid
probe
signal
amplif
nakajima
et
al
demonstr
sarscov
genom
alveolar
epithelium
macrophag
woman
sar
detail
clinic
cours
diseas
state
preferenti
local
viru
alveolar
cell
compon
rel
bronchial
epithelium
seen
time
death
suggest
alveolar
environ
might
permiss
viral
replic
could
also
account
high
incid
lower
respiratori
tract
involv
note
howev
studi
sar
human
bronchial
tracheal
biopsi
materi
nonfat
case
examin
therefor
whether
sarscov
replic
part
respiratori
tract
case
nonhuman
primat
remain
unansw
among
patient
die
later
two
week
symptom
onset
ish
ihc
signal
detect
postmortem
lung
tissu
even
lesion
morpholog
earlier
alveolar
edema
hyalin
membran
lung
show
heterogen
morpholog
progress
rel
uninvolv
area
interspers
among
advanc
lesion
find
suggest
decreas
sarscov
replic
consequ
decreas
intracellular
viral
copi
number
lung
tissu
first
two
week
diseas
termin
event
depend
continu
widespread
viral
replic
also
note
viral
load
detect
rtpcr
viral
cultur
nasopharyng
aspir
urin
stool
sampl
start
decreas
symptom
onset
correl
time
taken
develop
specif
antisar
antibodi
start
approxim
diseas
onset
identif
cell
infect
sarscov
human
yield
contradictori
find
et
al
use
ish
combin
ihc
found
dual
label
epitheli
cell
use
neg
stain
macrophag
antibodi
contrast
chen
hsiao
use
ish
demonstr
posit
signal
carboncontain
macrophag
also
within
vascular
lumina
later
report
also
taiwan
use
ish
demonstr
posit
signal
pneumocyt
macrophag
clear
patient
materi
woman
use
last
two
public
discrep
find
may
partial
explain
three
factor
choic
probe
age
patient
diseas
progress
et
al
use
membran
gene
whilst
chow
et
al
use
mixtur
probe
n
replicas
rep
found
greatest
intens
n
gene
minim
stain
rep
find
support
et
al
chow
et
al
mainli
epitheli
stain
also
definit
macrophag
dual
stain
suggest
although
epitheli
cell
main
target
sarscov
presenc
viral
rna
macrophag
repres
either
phagocytosi
lowlevel
replic
cell
none
previou
ishbas
studi
demonstr
ishposit
lymphocyt
report
gu
et
al
data
also
suggest
pneumocyt
may
infect
first
follow
macrophag
case
die
symptom
onset
stain
pneumocyt
cell
wherea
case
die
five
day
symptom
onset
pneumocyt
macrophag
stain
possibl
materi
use
et
al
studi
came
earli
case
shieh
et
al
describ
find
type
pneumocyt
posit
sarscov
one
patient
howev
studi
stain
appear
restrict
morpholog
type
pneumocyt
keep
find
haagman
et
al
howev
haagman
et
al
unabl
demonstr
macrophag
uptak
sarscov
also
found
occasion
bronchiolar
epitheli
cell
posit
sarscov
ish
ihc
electron
microscopi
note
studi
extent
immunohistochem
find
similar
seen
respiratori
syncyti
viru
rsv
infect
stain
bronchial
epitheli
cell
pneumocyt
macrophag
age
patient
also
import
sar
associ
greater
mortal
elderli
younger
age
group
laboratori
studi
shown
age
mice
infect
sarscov
sever
diseas
greater
cytokin
product
younger
mice
thu
differ
age
may
also
respons
differ
note
publish
result
spectrum
pulmonari
lesion
case
describ
studi
characterist
acut
resolv
stage
acut
lung
injuri
includ
dad
due
intrapulmonari
extrapulmonari
caus
bacteri
viral
infect
trauma
shock
etc
unlik
find
gu
et
al
demonstr
ishposit
cell
giant
cell
repeatedli
found
evid
posit
stain
ish
ihc
giant
cell
materi
giant
cell
seen
mainli
patient
diseas
durat
whether
mechan
format
seen
anim
model
need
investig
interestingli
multinucl
epitheli
cell
note
lung
infect
due
virus
measl
parainfluenza
respiratori
syncyti
virus
fact
none
chang
observ
present
case
uniqu
sarscov
infect
pathophysiolog
mechan
underli
dad
subsequ
pulmonari
fibrosi
investig
clinic
experiment
model
shown
proinflammatori
fibrogen
cytokin
pathway
activ
within
first
h
follow
pulmonari
insult
high
initi
level
activ
associ
persist
pulmonari
damag
increas
risk
subsequ
pulmonari
fibrosi
poor
outcom
dad
previou
studi
publish
viral
load
per
gram
tissu
use
quantit
pcr
quantit
pcr
method
shown
valu
determin
viral
load
virus
peripher
blood
epsteinbarr
viru
unlik
blood
lung
tissu
homogen
assess
viral
copi
per
gram
tissu
whether
tissu
sampl
contain
bronchu
scar
tissu
edema
fluid
exud
crucial
addit
blood
tissu
may
lead
falseposit
pcr
result
due
viremia
rather
viral
replic
tissu
studi
person
high
sarscov
viral
load
lung
tissu
good
correl
ihc
ish
result
lower
lung
organ
tissu
viral
load
show
neg
result
lower
viral
load
may
reflect
small
amount
residu
genom
previou
infect
compar
rsv
infect
report
stabl
well
acut
exacerb
chronic
obstruct
pulmonari
diseas
patient
possibl
explan
low
level
rtpcr
posit
lung
tissu
tissu
sar
patient
could
detect
sarscov
ihc
ish
furthermor
fatal
case
sar
patient
seroconvert
time
death
unpublish
data
howev
exclud
possibl
lowlevel
replic
tissu
detect
ihc
ish
due
possibl
limit
sensit
assay
studi
shown
alveolar
epithelium
macrophag
chief
target
sarscov
infect
human
lung
agreement
find
report
primat
model
diseas
predomin
infiltr
cell
lung
macrophag
agre
find
high
level
macrophagetroph
chemokin
vivo
respons
sarscov
infect
vitro
howev
rel
contribut
direct
viral
damag
versu
immunopatholog
pathogenesi
sar
remain
unclear
detect
level
intracellular
viral
rna
protein
lung
tissu
present
earliest
phase
diseas
disappear
wk
onset
symptom
although
found
four
posit
case
ish
ihc
patient
die
within
first
period
like
mani
neg
postmortem
case
would
posit
lung
biopsi
perform
earlier
lack
ihc
ish
stain
extrapulmonari
tissu
fatal
case
earli
sar
suggest
viral
involv
major
organ
may
widespread
data
base
rtpcr
result
previous
suggest
find
import
implic
clinic
therapeut
manag
sar
return
futur
antivir
therapi
institut
may
broader
window
opportun
intervent
antivir
therapi
exampl
influenza
treatment
within
h
requir
discern
clinic
impact
